Molecular Insight Pharmaceuticals Inc - Ownership and Business Overview

Healthcare ServicesCompany

Molecular Insight Pharmaceuticals Inc Ownership

Who owns Molecular Insight Pharmaceuticals Inc?

Molecular Insight Pharmaceuticals Inc is owned by Progenics Pharmaceuticals. It was acquired on January 22, 2013.

Molecular Insight Pharmaceuticals Inc Business Overview

Where is Molecular Insight Pharmaceuticals Inc headquartered?

Molecular Insight Pharmaceuticals Inc is headquartered in Cambridge, Massachusetts.

What sector is Molecular Insight Pharmaceuticals Inc in?

Molecular Insight Pharmaceuticals Inc is a healthcare services company.

When was Molecular Insight Pharmaceuticals Inc founded?

Molecular Insight Pharmaceuticals Inc was founded in 1997.

Healthcare Services M&A Summary in 2013

Out of 60 sectors in the Mergr database, healthcare services ranked 5 in number of deals in 2013. The largest healthcare services acquisition in 2013 was Elan - which was acquired by Perrigo Company for $8.6B.

Join Mergr to view all 329 acquisitions of healthcare services companies in 2013, including 45 acquisitions by private equity firms, and 284 by strategics.

Molecular Insight Pharmaceuticals, Inc

160 Second Street,
Cambridge, Massachusetts 02142
United States,

Molecular Insight Pharmaceuticals, Inc., a clinical-stage private biotechnology company with a small molecule chemistry pipeline aimed at enhancing cancer treatment.


 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.